- Home
- NPFD vs PSNL Comparison
NPFD vs PSNL Comparison
Compare NPFD & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPFD
- PSNL
- Stock Information
- Founded
- NPFD 2021
- PSNL 2011
- Country
- NPFD United States
- PSNL United States
- Employees
- NPFD N/A
- PSNL N/A
- Industry
- NPFD Trusts Except Educational Religious and Charitable
- PSNL Medical Specialities
- Sector
- NPFD Finance
- PSNL Health Care
- Exchange
- NPFD Nasdaq
- PSNL Nasdaq
- Market Cap
- NPFD 455.5M
- PSNL 460.7M
- IPO Year
- NPFD N/A
- PSNL 2019
- Fundamental
- Price
- NPFD $18.75
- PSNL $3.45
- Analyst Decision
- NPFD
- PSNL Strong Buy
- Analyst Count
- NPFD 0
- PSNL 5
- Target Price
- NPFD N/A
- PSNL $7.80
- AVG Volume (30 Days)
- NPFD 64.7K
- PSNL 883.3K
- Earning Date
- NPFD 01-01-0001
- PSNL 05-07-2025
- Dividend Yield
- NPFD 6.28%
- PSNL N/A
- EPS Growth
- NPFD N/A
- PSNL N/A
- EPS
- NPFD N/A
- PSNL N/A
- Revenue
- NPFD N/A
- PSNL $84,614,000.00
- Revenue This Year
- NPFD N/A
- PSNL N/A
- Revenue Next Year
- NPFD N/A
- PSNL $27.78
- P/E Ratio
- NPFD N/A
- PSNL N/A
- Revenue Growth
- NPFD N/A
- PSNL 15.15
- 52 Week Low
- NPFD $14.50
- PSNL $1.14
- 52 Week High
- NPFD $18.07
- PSNL $7.20
- Technical
- Relative Strength Index (RSI)
- NPFD 44.25
- PSNL 39.63
- Support Level
- NPFD $18.75
- PSNL $3.33
- Resistance Level
- NPFD $18.98
- PSNL $3.65
- Average True Range (ATR)
- NPFD 0.14
- PSNL 0.25
- MACD
- NPFD 0.01
- PSNL 0.03
- Stochastic Oscillator
- NPFD 47.73
- PSNL 19.17
About NPFD Nuveen Variable Rate Preferred & Income Fund
Nuveen Variable Rate Preferred&Income is a newly organized, diversified, closed-end management investment company. The Fund's investment objective is to seek to provide a high level of current income and total return.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.